<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
                      "http://www.w3.org/TR/REC-html40/loose.dtd">
<HTML>
<HEAD>
<TITLE>extropians: MED: Angiogenesis Inhibitors</TITLE>
<META NAME="Author" CONTENT="GBurch1@aol.com (GBurch1@aol.com)">
<META NAME="Subject" CONTENT="MED: Angiogenesis Inhibitors">
</HEAD>
<BODY BGCOLOR="#FFFFFF" TEXT="#000000">
<H1>MED: Angiogenesis Inhibitors</H1>
<!-- received="Sat Mar 25 15:06:05 2000" -->
<!-- isoreceived="20000325220605" -->
<!-- sent="Sat, 25 Mar 2000 17:06:58 EST" -->
<!-- isosent="20000325220658" -->
<!-- name="GBurch1@aol.com" -->
<!-- email="GBurch1@aol.com" -->
<!-- subject="MED: Angiogenesis Inhibitors" -->
<!-- id="4.2053d1c.260e9282@aol.com" -->
<STRONG>From:</STRONG> <A HREF="mailto:GBurch1@aol.com?Subject=Re:%20MED:%20Angiogenesis%20Inhibitors&In-Reply-To=&lt;4.2053d1c.260e9282@aol.com&gt;"><EM>GBurch1@aol.com</EM></A><BR>
<STRONG>Date:</STRONG> Sat Mar 25 2000 - 15:06:58 MST
<P>
<!-- next="start" -->
<UL>
<LI><STRONG>Next message:</STRONG> <A HREF="5796.html">Rob Sweeney: "Re: a to-do list for the next century"</A>
<LI><STRONG>Previous message:</STRONG> <A HREF="5794.html">Natasha Vita-More: "Re: a to-do list for the next century"</A>
<!-- nextthread="start" -->
<LI><STRONG>Next in thread:</STRONG> <A HREF="5799.html">Robert J. Bradbury: "Re: MED: Angiogenesis Inhibitors"</A>
<LI><STRONG>Reply:</STRONG> <A HREF="5799.html">Robert J. Bradbury: "Re: MED: Angiogenesis Inhibitors"</A>
<!-- reply="end" -->
<LI><STRONG>Messages sorted by:</STRONG> 
<A HREF="date.html#5795">[ date ]</A>
<A HREF="index.html#5795">[ thread ]</A>
<A HREF="subject.html#5795">[ subject ]</A>
<A HREF="author.html#5795">[ author ]</A>
</UL>
<HR NOSHADE><P>
<!-- body="start" -->
<P>
There have been a couple of mentions recently of antiangiogenesis drugs.  
<BR>
After the big splash a couple of years ago, things have been quiet during the 
<BR>
hard work of clinical trials.  Any word from the front on how those trials 
<BR>
are going?
<BR>
<P>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Greg Burch     &lt;<A HREF="mailto:GBurch1@aol.com?Subject=Re:%20MED:%20Angiogenesis%20Inhibitors&In-Reply-To=&lt;4.2053d1c.260e9282@aol.com&gt;">GBurch1@aol.com</A>&gt;----&lt;<A HREF="mailto:gburch@lockeliddell.com?Subject=Re:%20MED:%20Angiogenesis%20Inhibitors&In-Reply-To=&lt;4.2053d1c.260e9282@aol.com&gt;">gburch@lockeliddell.com</A>&gt;
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Attorney  :::  Vice President, Extropy Institute  :::  Wilderness Guide
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="http://users.aol.com/gburch1">http://users.aol.com/gburch1</A>   -or-   <A HREF="http://members.aol.com/gburch1">http://members.aol.com/gburch1</A>
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ICQ # 61112550
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;We never stop investigating. We are never satisfied that we know 
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;enough to get by. Every question we answer leads on to another    
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;question. This has become the greatest survival trick of our species.&quot;
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-- Desmond Morris
<BR>
<P><!-- body="end" -->
<HR NOSHADE>
<UL>
<!-- next="start" -->
<LI><STRONG>Next message:</STRONG> <A HREF="5796.html">Rob Sweeney: "Re: a to-do list for the next century"</A>
<LI><STRONG>Previous message:</STRONG> <A HREF="5794.html">Natasha Vita-More: "Re: a to-do list for the next century"</A>
<!-- nextthread="start" -->
<LI><STRONG>Next in thread:</STRONG> <A HREF="5799.html">Robert J. Bradbury: "Re: MED: Angiogenesis Inhibitors"</A>
<LI><STRONG>Reply:</STRONG> <A HREF="5799.html">Robert J. Bradbury: "Re: MED: Angiogenesis Inhibitors"</A>
<!-- reply="end" -->
<LI><STRONG>Messages sorted by:</STRONG> 
<A HREF="date.html#5795">[ date ]</A>
<A HREF="index.html#5795">[ thread ]</A>
<A HREF="subject.html#5795">[ subject ]</A>
<A HREF="author.html#5795">[ author ]</A>
</UL>
<!-- trailer="footer" -->
<HR NOSHADE>
<P>
<SMALL>
<EM>
This archive was generated by <A HREF="http://www.hypermail.org/">hypermail 2b29</A> 
: <EM>Thu Jul 27 2000 - 14:06:23 MDT</EM>
</EM>
</SMALL>
</BODY>
</HTML>
